Product # 532 is MAPKKide® Plus Specific Substrate for Anthrax Lethal Factor. This peptide is remarkable in its resistance to non-specific cleavage by enzymes which may be present in natural samples. MAPKKide® Plus carries the fluorophore 7-amido-4-methylcoumarin (AMC).
Product # 769B Anti-Lethal Factor from B. anthracis (chicken lgY) may be used to capture LF. Additionally, we have demonstrated that the antibody # 769B may be used to capture LF and use the MAPKKide®substrate.
Bacillus anthracis is the etiological agent of anthrax. Major virulence factors produced by Bacillus anthracis are the gamma-linked, poly-D-glutamic acid capsule and an exotoxin composed of three components, protective antigen (PA), lethal factor (LF), and edema factor (EF). PA is the cell binding and delivery component where LF and EF are enzymes which cause changes in infected cells. These proteins are not toxic, held separately; but, act as toxins in binary combinations. Combination of the cell binding component, PA, with LF is termed lethal toxin (LeTx) and PA with EF is edema toxin (EdTx).
After secretion, in a cellular environment, the 83 kDa PA protein is cleaved by membrane peptidases, producing 63 kDa carboxy terminal fragments which combine, often in groups of seven forming a heptamer. Cleavage is an essential step in allowing oligomerization and in exposing the binding sites on PA oligomer for EF and LF. The assembled PA complex and associated LF or EF enters the cell through endocytosis. PA mediates the transfer of LF and EF to the cytoplasm where these enzymes recognize and act on their targets. The LF component, a zinc-dependent metalloprotease, cleaves the mitogen-activated protein kinase kinase (MAPKK), impairing its function and thereby blocking the MAPK signaling pathway. EF is a calmodulin-dependent adenylate cyclase which creates in the cell excess amounts of cyclic-AMP, disrupting AMP-mediated signaling. In the early stage of infection, LF and EF work together to block the patient’s immune response.
List provides several forms of PA, LF and EF. FRET peptide substrates containing a cleavage site for anthrax LF are available as MAPKKide® and can be used to assess the enzymatic activity of LF. Antibodies directed to PA and LF are also in the List Labs catalog.
Protective antigen (PA) is the receptor binding component of anthrax toxin. The original 83 kDa protein is cleaved by cellular proteases to form an activated 63 kDa monomer, PA63. In this form, PA63 aggregates with other PA63 molecules forming a ring-shaped heptamer. PA63 has binding sites specific for the enzymes LF and EF allowing for attachment, endocytosis, and translocation. PA63 should be used in approximately seven-fold excess along with either EF or LF to intoxicate cells.
List Labs provides PA in several different forms,
Product #174 is PA63, which has been created by enzymatic digestion and purified;
Product #177 is PA20, the approximately 20 kDA fragment cleaved from PA.
Product #175 is purified PA63 conjugated to FITC for visualization.
Product #771 purified IgG from goat, is directed to PA.
Lethal Factor (LF) is the enzymatic subunit of anthrax lethal toxin. When intoxicating a cell, LF binds to PA on the cell surface and translocates through a pore made by seven PA monomers. List Labs offers several forms of LF, all made recombinantly in the native Bacillus anthracis host.
Product #169 (LF-A), is native LF, recommended for most users and is provided in a liquid form;
Product #172 (LF-HMA), the original LF made by List Labs, has been found to carry two additional amino acids, histidine and methionine, on the N-terminal. This product is recommended only for use in assays validated with this product; and finally
Product #176 (LF E687C) is an enzymatic inactive form of LF, carrying a Glu to Cys substitution in the zinc-binding site.
LF Substrates and Antibodies
List Labs has designed substrates available as MAPKKide® which mimic the native targets for LF, proteins in the MAPKK family. These FRET peptides contain the cleavage site for LF and fluorophores which are quenched based on fluorescence resonance energy transfer (FRET). Cleavage of each substrate by LF releases the fluorophore creating an increase in fluorescent intensity. The following are available LF peptide substrates carrying three different fluorophores:
Product #532 is MAPKKide® Plus Specific Substrate for Anthrax Lethal Factor. This peptide is remarkable in its resistance to non-specific cleavage by enzymes which may be present in natural samples. MAPKKide® Plus carries the fluorophore 7-amido-4-methylcoumarin (AMC).
Product #530 is MAPKKide® utilizing the o-Abz/Dnp FRET pair. A calibration peptide, Product #539 is available for use as an unquenched calibration peptide for Product #530
Product #531 is MAPKKide® with the FRET pair DABCYL/FITC.
List offers pairs of antibodies directed to LF, suitable for use in ELISAs.
Product #768L affinity purified and biotinylated Anti-Lethal Factor from B. anthracis (chicken lgY) works to detect LF as described in the C of A.
Product #769B Anti-Lethal Factor from B. anthracis (chicken lgY) may be used to capture LF. Additionally, we have demonstrated that the antibody #769B may be used to capture LF and used with the MAPKKide® Plus substrate to quantitate the amount of LF in a complex matrix.
Edema Factor (EF) is the enzymatic subunit of anthrax edema toxin. When intoxicating a cell, EF binds to PA on the cell surface and translocates through a pore made by seven PA monomers. List Labs offers two forms of EF, made recombinantly in the native Bacillus anthracis host.
Product #178 is comprised of the native sequence with an additional amino acid, histidine on the N-terminal.
Product #173 is a mutant S414N EF mutant with reduced adenylate cyclase activity.
An antibody for EF is also available,
Product #773L, goat anti-edema factor. Use in a dot blot and direct ELISA is described in the C of A.
A fast, sensitive, specific and accurate detection method to determine active infection Dr. Nancy Shine (408) 874-1305 NShine@ListLabs.com [Campbell, CA, 11/29/2018] • Method to detect Anthrax before it’s deadly • Anthrax is a problem for livestock • Test method is both specific and sensitive for Anthrax • List Labs is looking to partner on this […]
By: Rachel Berlin, Marketing Manager Microbiome research is uncovering the enormous potential for developing drugs, such a live biotherapeutic products, from the microbiome. This burgeoning field is the future of medicine. List Labs is excited and proud to support microbiome research by providing reagents to scientists studying the human microbiome. Below is a list of microbiome […]
By: Nancy Shine, PhD, Director of R&D, List Labs A fast, sensitive, specific and accurate detection method to determine active infection by Bacillus anthracis in plasma has been developed at List Biological Laboratories. Bacillus anthracis is regarded as a major biological warfare threat. The inhalation form of Bacillus anthracis infection can kill quickly. While antibiotic […]
By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at ASM Biothreats February 12-14th. The conference will be held in Baltimore, Maryland at the Hilton Hotel. Thought leaders in academia, industry and government will gather to present and discuss the latest developments in the emerging field of biothreats. This year’s conference has […]
By: Rachel Berlin, Marketing Manager Over 20 Scientific Posters Available on our website Scientific posters are a great way to visually display complex scientific issues. List Labs has a large list of scientific posters published on our website under the specific products they pertain to. We have been getting a lot of requests lately […]
By: Nancy Shine, Ph.D., Director of Research & Development List Biological Laboratories, Inc. has designed a fluorescently labeled substrate for specific and quantitative detection of anthrax lethal factor in plasma. Bacillus anthracis is regarded as a major biological warfare threat. The inhalation form of Bacillus anthracis infection can kill quickly. While antibiotic treatment can clear […]
By: Suzanne Canada, Ph.D. Tanager Medical Writing An exciting report was released in October about a new class of targeted anti-tumor drugs, in which genetically engineered stem cells were used to deliver cytotoxins to brain tumors.1 Brain cancers known as glioblastomas (GBM) are notoriously difficult to treat because the tumors often re-grow after surgery and because […]
By: Suzanne Canada, Ph.D. Tanager Medical Writing Three anthrax toxin components—Protective antigen (PA), edema factor (EF) and lethal factor (LF) are available for research purposes from LIST Biological Laboratories, separately at a high level of purification. At least two out of three of these components are necessary to enter a mammalian cell and exert […]
By: Suzanne Canada, Ph.D. Tanager Medical Writing Vaccines have been used to help control diseases for more than 200 years and are the common practice for children and adults. Childhood vaccination has substantially reduced the morbidity and mortality from infectious diseases in much of the developed world, and influenza vaccinations have reduced the impact […]
What Are Toxin Neutralization Assays & How Do They Work? For clinical detection or vaccine testing, it is hard to beat a toxin neutralization assay. Toxin neutralization assays (TNA) assess the ability of antibodies to protect cells in culture from the cytotoxic affect of the specific toxins. Interestingly, these assays may be used for sensitive […]